Press release
Anti Asthma Drugs Market 2018; Leading Players Baxter International, Baxter International, Hikma Pharmaceuticals, AbbVie etc. – Outlook 2023
The Global Anti-Asthma Drugs Market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region. On the basis of drug class, this market has been segmented into bronchodilators, corticosteroids, leukotriene antagonists, mast cell stabilizers, monoclonal antibody, and others. Bronchodilators have been further segmented into anticholinergics, beta agonists, and Xanthines.Based on the route of administration, the market has been segmented into inhaled, intravenous, oral, and subcutaneous. The therapy-based segmentation of market comprises of curative therapy and preventive therapy.
Request Sample Report at https://www.marketresearchfuture.com/sample_request/2353
The trigger-based segmentation of the market covers adult-onset asthma, child-onset asthma, cough-induced asthma, exercise-induced asthma, nocturnal asthma, occupational asthma, steroid-resistant asthma. By type, the market has been segmented into allergic (extrinsic) asthma and non-allergic (intrinsic) asthma.
Anti-Asthma Drugs Market - Overview
With the air pollution rising around the world, the number of asthma patients is also increasing. Therefore the market for the drugs necessary for its treatment is rising. Market Research Future (MRFR) has published a research report that envisions surge in the global anti-asthma drugs market with 5.94% CAGR (Compound Annual Growth Rate) between 2015 and 2022. In terms of cash, the market is expected to rise with the US $ 28.3 bn by the end of the forecast period.
Observing the market structure, this report evaluates the future growth potential of the market and analyzes the strategies of the key players in the market. It also follows the competitive developments such as joint ventures, new product developments, mergers and acquisitions, new product developments (R & D) in the market.
According to this report, the key factors that drive this growth of this market include growing awareness of the benefits of modern drug therapy, the great potential of biologics, growth in patients due to increasing pollution, and problems arising from consumerism & unhealthy lifestyles. Constraints that can make the market growth hit a roadblock are the fear among leading drug brands regarding the loss of patents of leading brands, and increasing fragmentation of markets and generic penetration.
Anti-Asthma Drugs Market - Key Players
The key players in the global anti-asthma drugs market include AstraZeneca PLC (UK), Boehringer Ingelheim (Germany), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline PLC (UK), Merck & Co. Inc. (USA), Novartis International AG (Switzerland), Sunovion Pharmaceuticals Inc (USA), and Teva Pharmaceutical Industries (Israel).
Anti-Asthma Drugs Market - Regional Analysis
The regional segmentation of the global anti-asthma drugs market segments the market into regional markets namely The Americas (North America & South America), Europe, Asia Pacific, the Middle East & Africa (MEA). Due to the availability of advanced medical facilities, North America is not only a bigger market than South America, but it is also the biggest market for anti-asthma drugs. In this region, the biggest country-wide market is the United States of America (USA). Many key players in the market are based here.
Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/anti-asthma-drugs-market-2353
Europe is the second largest market as it is also equipped with advanced medical facilities. The cream of the market in this region covers, like France, Germany, Italy, Spain, and the United Kingdom (UK) followed by the rest of Europe. The Asia Pacific is witnessing major newer cases due to greater screening and better health care facilities distribution. During the forecast period, this region is expected to emerge as the fastest growing market. The most important markets in this region are China, India, Japan, and South Korea, followed by the rest of Asia Pacific. The MEA region is a small market due to lack of awareness about anti-asthma, lack of education, lack of technological development, poor healthcare, and healthcare not considered a priority by most governments.
Anti-Asthma Drugs Market - Latest Industry News
• According to research conducted in the Indian Institute of Science (IISc), Bengaluru, a drug called Pranlukast that is useful for treating asthma, has been found to be effective against tuberculosis. 23 June 2018
• Morepen Laboratories Ltd. has received approval from the United States Food and Drug Administration (USFDA) for both its bulk drugs manufacturing facilities situated in Himachal Pradesh, India. While the Baddi facility has got approval for the manufacture of the bulk drug “Atorvastatin Calcium,” a Cholesterol reducing drug, the Masulkhana facility has got approval for manufacturing an anti-asthma bulk drug "Montelukast Sodium" for export to the US market. 30 Jul 2018
Major Point by Table of Contents
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Anti-Asthma Drugs Market, By Type
6 Global Anti-Asthma Drugs Market, By Trigger
7 Global Anti-Asthma Drugs Market, By Drug Class
8 Global Anti-Asthma Drugs Market, By Therapy
9 Global Anti-Asthma Drugs Market, By Route of Administration
10 Global Anti-Asthma Drugs Market, By Regions
11 Company Landscape
12 Company Profile
13 Others
14 Appendix
Get Prime Discount at https://www.marketresearchfuture.com/check-discount/2353
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti Asthma Drugs Market 2018; Leading Players Baxter International, Baxter International, Hikma Pharmaceuticals, AbbVie etc. – Outlook 2023 here
News-ID: 1444112 • Views: …
More Releases from Market Research Future

Procurement Intelligence for Civil Construction Industry in Australia Market Ove …
Category Intelligence Insights for the Civil Construction Industry in Australia
The civil construction industry in Australia plays a pivotal role in shaping the nation's infrastructure, driving economic growth, and creating employment opportunities. As the industry evolves, understanding the key trends, challenges, and opportunities becomes essential for stakeholders. Here are the latest category intelligence insights for the Australian civil construction sector:
Procurement intelligence is a critical enabler of success in the civil construction…

Procurement Intelligence for Digital Payment Services Market Poised for Explosiv …
•➤ Procurement Intelligence for Digital Payment Services Market: Comprehensive Insights and Trends
The Procurement Intelligence digital payment services market has witnessed unprecedented growth over the past decade, driven by the increasing adoption of cashless transactions, the expansion of e-commerce, and the proliferation of mobile payment solutions. Procurement intelligence plays a pivotal role in optimizing purchasing strategies, enhancing supplier relationships, and ensuring cost efficiency in this dynamic industry. Digital payment services encompass…

Oil & Gas Asset Integrity Management Service Market Trends, Growth, and Insights
As per the Market Research Future (MRFR)'s analysis, the Oil And Gas Asset Integrity Management Service Market is Projected to reach a market value of USD 22 billion while flourishing at a CAGR of 5.4% by 2032.
The Oil & Gas Asset Integrity Management Service Market plays a critical role in ensuring the safety, reliability, and efficiency of infrastructure and operations in the oil and gas industry. With increasing demand for…

Produce Packaging Market is anticipated to exceed USD 52.56 billion by 2032, gro …
Overview of the Produce Packaging Market
The produce packaging market plays a crucial role in the fresh food supply chain by ensuring that fruits, vegetables, and other perishable goods are safely transported from farms to consumers. This market is influenced by a combination of consumer trends, environmental concerns, technological innovations, and the rising demand for convenience. As the global population continues to grow, the need for effective and sustainable packaging solutions…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…